查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1226743

细胞增生套件的全球市场:现状分析与预测(2022年～2028年)

Cell Proliferation Kit Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 142 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球细胞增生套件的市场规模，在预测期间内预计以约7％的年复合成长率成长。癌症和肿瘤的患者数增加，早期诊断增加，为了减轻医疗费负担的政府配合措施增加，医疗的认识高涨，促进市场成长。

本报告提供全球细胞增生套件市场的相关调查，市场洞察，市场趋势，竞争模式，企业概要等全面性资讯。

目录

第1章 市场简介

  • 市场定义
  • 主要的目标
  • 相关利益者
  • 限制

第2章 调查手法或假设

  • 细胞增生套件市场调查流程
  • 细胞增生套件市场调查手法
  • 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对细胞增生套件市场的影响

第6章 全球细胞增生套件市场收益(2022年～2028年)

第7章 市场洞察:各类型

  • 萤光细胞生存套件
  • 比色细胞生存套件
  • 生物冷光细胞生存套件
  • 其他

第8章 市场洞察:各用途

  • 製药、生物科技企业
  • 学术、研究机关
  • 其他

第9章 市场洞察:各地区

  • 北美
    • 美国
    • 加拿大
    • 其他的北美
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 其他的亚太地区
  • 其他

第10章 细胞增生套件的市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第11章 细胞增生套件的市场机会

第12章 细胞增生套件的市场趋势洞察

第13章 需求面和供给方面的分析

  • 需求面分析
  • 供给面

第14章 价值链分析

第15章 价格分析

第16章 策略性洞察能力

第17章 竞争模式

  • 竞争情形
    • 波特的五力分析

第18章 企业概要

  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • GE Healthcare
  • PerkinElmer Inc
  • Bio-Rad Laboratories, Inc.
  • Becton Dickinson and Co
  • Biotium
  • Agilent Technologies Inc
  • F. Hoffmann-La Roche AG
  • Biological Industries

第19章 免责声明

简介目录
Product Code: UMME211630

The cell proliferation kit market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Cell replication, or the process of cell proliferation, is essential for maintaining the homeostasis of adult tissues by replacing dead cells with fresh ones. This process begins during embryogenesis. Abnormal cell proliferation is seen in a few disease conditions, such as cancer. So, in both in vitro and in vivo settings, cell proliferation assay kits gained popularity in the clinical diagnosis of various disease indications. These are used in research studies of cell activation, cytotoxicity assessment, and clinical trials to determine therapeutic efficacy. The growing demand for cell proliferation kits can be attributed to the rising numbers of patients with cancer and tumors across the globe. For instance, according to the World Health Organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Owing to the glaring statistics the rising prevalence of cancer leads to higher demand for cell proliferation kits across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the cell proliferation kit market is anticipated to grow on account of the increasing number of early diagnostic procedures. In addition, the rise in government initiatives to control the healthcare burden and growing healthcare awareness among people drive market growth. However, some of the restraints in the market including the high cost of kits and lack of trained professionals are impeding the growth of this market all over the world.

Based on the type, the cell proliferation kit market is segmented into fluorometric cell viability kits, colorimetric cell viability kits, bioluminescent cell viability kits, and others. The colorimetric cell viability kits segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe. This method for detecting cell viability is cost-effective and easy to retrieve throughout data. It is also anticipated that the widespread use of this technique to identify various cellular activities, such as DNA synthesis, metabolic activity, and ATP production, will spur the expansion of the future market segment.

Based on the application, the market is fragmented into pharmaceutical and biotechnology companies, academic institutes and research laboratories, and others. The pharmaceutical and biotechnology companies segment grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. Cell proliferation kits are used in academic institutions and research labs to identify cell damage by monitoring how the cells respond to various stimuli, such as hydrogen peroxide, antibiotics, etc.

For a better understanding of the market adoption of the cell proliferation kit, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the cell proliferation kit industry owing to the growing number of new cancer cases like melanoma, urothelial carcinoma, lung cancer, and others each year in the region. Moreover, the presence of well-established healthcare facilities, growing advanced technologies, as well as rising healthcare spending boost the market growth in this region. For instance, according to the centers for Medicare & Medicaid services, U.S. healthcare spending grew 2.7% in 2021, reaching USD 4.3 trillion or USD 12,914 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 18.3%.

Some of the major players operating in the market include: Thermo Fisher Scientific Inc, Merck KGaA, GE Healthcare, PerkinElmer Inc, Bio-Rad Laboratories, Inc., Becton Dickinson and Co, Biotium, Agilent Technologies Inc, F. Hoffmann-La Roche AG, and Biological Industries, among others. Several M&As along with partnerships have been undertaken.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Cell Proliferation Kit Market
  • 2.2. Research Methodology of the Cell Proliferation Kit Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CELL PROLIFERATION KIT MARKET

6 GLOBAL CELL PROLIFERATION KIT MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Fluorometric Cell Viability Kits
  • 7.2. Colorimetric Cell Viability Kits
  • 7.3. Bioluminescent Cell Viability Kits
  • 7.4. Others

8 MARKET INSIGHTS BY APPLICATION

  • 8.1. Pharmaceutical and Biotechnology Companies
  • 8.2. Academic Institutes and Research Laboratories
  • 8.3. Others

9 MARKET INSIGHTS BY REGION

  • 9.1 NORTH AMERICA CELL PROLIFERATION KIT MARKET
    • 9.1.1 U.S.
    • 9.1.2 Canada
    • 9.1.3 Rest of North America
  • 9.2 EUROPE CELL PROLIFERATION KIT MARKET
    • 9.2.1 Germany
    • 9.2.2 France
    • 9.2.3 U.K.
    • 9.2.4 Spain
    • 9.2.5 Italy
    • 9.2.6 Rest of Europe
  • 9.3 ASIA PACIFIC CELL PROLIFERATION KIT MARKET
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4. Australia
    • 9.3.4 Rest of Asia Pacific
  • 9.4 REST OF WORLD CELL PROLIFERATION KIT MARKET

10 CELL PROLIFERATION KIT MARKET DYNAMICS

  • 10.1 Market Drivers
  • 10.2 Market Challenges
  • 10.3 Impact Analysis

11 CELL PROLIFERATION KIT MARKET OPPORTUNITIES

12 CELL PROLIFERATION KIT MARKET TRENDS & INSIGHTS

13 DEMAND AND SUPPLY SIDE ANALYSIS

  • 13.1 Demand Side Analysis
  • 13.2 Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1 Porter's Five forces analysis

18 COMPANY PROFILED

  • 18.1. Thermo Fisher Scientific Inc
  • 18.2. Merck KGaA
  • 18.3. GE Healthcare
  • 18.4. PerkinElmer Inc
  • 18.5. Bio-Rad Laboratories, Inc.
  • 18.6. Becton Dickinson and Co
  • 18.7. Biotium
  • 18.8. Agilent Technologies Inc
  • 18.9. F. Hoffmann-La Roche AG
  • 18.10. Biological Industries

19 DISCLAIMER